Cargando…
Quantitative proteomic analysis by iTRAQ(® )for the identification of candidate biomarkers in ovarian cancer serum
BACKGROUND: Ovarian cancer is the most lethal gynecologic malignancy, with the majority of cases diagnosed at an advanced stage when treatments are less successful. Novel serum protein markers are needed to detect ovarian cancer in its earliest stage; when detected early, survival rates are over 90%...
Autores principales: | Boylan, Kristin LM, Andersen, John D, Anderson, Lorraine B, Higgins, LeeAnn, Skubitz, Amy PN |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2893134/ https://www.ncbi.nlm.nih.gov/pubmed/20546617 http://dx.doi.org/10.1186/1477-5956-8-31 |
Ejemplares similares
-
i-Tracker: For quantitative proteomics using iTRAQ™
por: Shadforth, Ian P, et al.
Publicado: (2005) -
Potential tumor biomarkers identified in ovarian cyst fluid by quantitative proteomic analysis, iTRAQ
por: Kristjansdottir, Björg, et al.
Publicado: (2013) -
Quantitative Serum Proteomic Analysis of Essential Hypertension Using iTRAQ Technique
por: Xu, Jing-Wen, et al.
Publicado: (2017) -
Understanding Ovarian Cancer: iTRAQ-Based Proteomics for Biomarker Discovery
por: Swiatly, Agata, et al.
Publicado: (2018) -
iTRAQ-Based Quantitative Proteomic Analysis of the Initiation of Head Regeneration in Planarians
por: Geng, Xiaofang, et al.
Publicado: (2015)